Rivon Pharmaceutical Llp - Due diligence report

A 360° intelligence report on Rivon Pharmaceutical Llp: trust score, financial health, credit view, compliance, directors, growth and distre…

2018-02-02 Mehsana, Gujarat Active
Share
Connect MCP
RP Rivon Pharmaceutical Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Rivon Pharmaceutical Llp — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Rivon Pharmaceutical Llp is assessed as Low Risk with a Trust Score of 78/100. Rivon Pharmaceutical Llp is an active limited liability partnership incorporated in 2018, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 10 Oct 2026 from the latest processed filings. Rivon Pharmaceutical Llp snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 2 open (38.90 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
The Kukarwada Nagarik Sahkari Bank Limited2 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VIMARSHKUMAR PATEL JAGDISHBHAI 01234567 Director 01/04/2018 6 yrs Approved
MRUGESHKUMAR SHANTILAL DESAI 01234567 Director 01/04/2018 6 yrs Approved
HARDIKKUMAR MANUBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
HARSH H VYAS 01234567 Director 01/04/2018 6 yrs Approved
AMITKUMAR JAYANTILAL PATEL 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 8 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 38.90 Lakh already registered.
  • Compliance record supports lending.
Investor view73/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
17 Apr 2023
Charge created
The Kukarwada Nagarik Sahkari Bank Limited - 38.90 Lakh
15 Feb 2021
Director ceased
PRAKASH SHANTILAL DESAI
Director ceased
KULDIP BABULAL CHAUDHARI
26 Apr 2018
Charge created
The Kukarwada Nagarik Sahkari Bank Limited
02 Feb 2018
Incorporated
Registered with Roc Ahmedabad
Director appointed
VIMARSHKUMAR PATEL JAGDISHBHAI (Designated Partner)
Director appointed
MRUGESHKUMAR SHANTILAL DESAI (Designated Partner)
Director appointed
HARDIKKUMAR MANUBHAI PATEL (Designated Partner)
Director appointed
HARSH H VYAS (Designated Partner)
Director appointed
AMITKUMAR JAYANTILAL PATEL (Designated Partner)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rishabh Lifescience Private Limited U24299GJ2019PTC111251 Mahesana, Gujarat
Kriah Software Solutions And E-Governance Private Limited U72100GJ2014PTC080171 Mahesana, Gujarat
Abzo Motors Private Limited U34300GJ2019PTC107016 Mahesana, Gujarat
Brahm Anhadnad Foundation U85500GJ2024NPL152348 Mahesana, Gujarat
Decro Pharma Private Limited U24210GJ2020PTC117562 Mahesana, Gujarat
Mascot Infrastructure (I) Private Limited U45201GJ2008PTC053200 Mahesana, Gujarat
Ecorrect Private Limited U25209GJ2020PTC113442 Mahesana, Gujarat
Axita Cotton Limited L17200GJ2013PLC076059 Mahesana, Gujarat
Hemali Electricals Private Limited U31401GJ2014PTC078596 Mahesana, Gujarat
MGL TRANSLINE LLP AAW-0130 Mahesana, Gujarat
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Rivon Pharmaceutical Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Rivon Pharmaceutical Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Rivon Pharmaceutical Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Rivon Pharmaceutical Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Rivon Pharmaceutical Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Rivon Pharmaceutical Llp an active company?

Rivon Pharmaceutical Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Rivon Pharmaceutical Llp financially healthy?

Rivon Pharmaceutical Llp has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Rivon Pharmaceutical Llp?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Rivon Pharmaceutical Llp?

See the directors and ownership sections above for board and shareholding detail. 5 active director(s) are on record.

Does Rivon Pharmaceutical Llp have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Rivon Pharmaceutical Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Rivon Pharmaceutical Llp?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.